Real Heart (HEART) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.026x

Based on the latest financial reports, Real Heart (HEART) has a cash flow conversion efficiency ratio of -0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.94 Million ≈ $-208.80K USD) by net assets (Skr74.35 Million ≈ $8.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Real Heart net asset quality index to measure how much of total assets are equity-financed.

Real Heart - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Real Heart's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check HEART cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Real Heart Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Real Heart ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ICG Enterprise Trust PLC LSE:ICGT	0.073x
General Engineering Public Company Limited BK:GEL	0.044x
AB Panevezio Statybos Trestas STU:YK3	-0.069x
Spolytech Co. Ltd KQ:050760	0.084x
Lion Metal Works Tbk JK:LION	0.029x
Prasidha Aneka Niaga Tbk JK:PSDN	-0.096x
Gamma Communications PLC LSE:GAMA	0.112x
Portage Biotech Inc NASDAQ:PRTG	-2.245x

Annual Cash Flow Conversion Efficiency for Real Heart (2014–2024)

The table below shows the annual cash flow conversion efficiency of Real Heart from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Real Heart worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr67.34 Million ≈ $7.25 Million	Skr-12.99 Million ≈ $-1.40 Million	-0.193x	+36.81%
2023-12-31	Skr82.04 Million ≈ $8.83 Million	Skr-25.05 Million ≈ $-2.70 Million	-0.305x	-304.00%
2022-12-31	Skr97.65 Million ≈ $10.51 Million	Skr-7.38 Million ≈ $-794.22K	-0.076x	+12.86%
2021-12-31	Skr111.29 Million ≈ $11.98 Million	Skr-9.65 Million ≈ $-1.04 Million	-0.087x	+33.92%
2020-12-31	Skr71.69 Million ≈ $7.72 Million	Skr-9.41 Million ≈ $-1.01 Million	-0.131x	-5.77%
2019-12-31	Skr59.00 Million ≈ $6.35 Million	Skr-7.32 Million ≈ $-788.00K	-0.124x	+62.85%
2018-12-31	Skr19.30 Million ≈ $2.08 Million	Skr-6.45 Million ≈ $-693.86K	-0.334x	+6.75%
2017-12-31	Skr27.52 Million ≈ $2.96 Million	Skr-9.86 Million ≈ $-1.06 Million	-0.358x	-66.32%
2016-12-31	Skr16.20 Million ≈ $1.74 Million	Skr-3.49 Million ≈ $-375.55K	-0.215x	+8.16%
2015-12-31	Skr5.97 Million ≈ $642.14K	Skr-1.40 Million ≈ $-150.60K	-0.235x	+0.45%
2014-12-31	Skr7.50 Million ≈ $806.85K	Skr-1.77 Million ≈ $-190.08K	-0.236x	--

About Real Heart

ST:HEART Sweden Medical Devices

Market Cap

$10.73 Million

Skr99.72 Million SEK

Market Cap Rank

#26848 Global

#581 in Sweden

Share Price

Skr19.95

Change (1 day)

+2.31%

52-Week Range

Skr13.15 - Skr29.00

All Time High

Skr1625.78